---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-152826"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:35:36.828677+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma stockholders approve reverse stock split with ratio 1:30 to 1:50

## Summary
- Elected Pasha Sarraf, Peter A. Kiener, Frank Morich, Pamela Garzone, Patrick Verheyen, and Jill Broadfoot to the Board.
- Ratified RSM US LLP as independent auditor for FY2026 with 58,982,168 votes for.
- Approved non-binding advisory say-on-pay with 31,388,709 for, 4,239,819 against.
- Approved reverse stock split amendment at 51,011,729 for; ratio range 1-for-30 to 1-for-50 at Board's discretion.
- Prior CEO Usman Azam resigned March 26, 2026; votes for him were disregarded.

## SEC filing metadata
- accession: 0001193125-26-152826
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312526152826/0001193125-26-152826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312526152826/cue-20260413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-152826
- JSON: https://secwatch.observer/filing/0001193125-26-152826.json
- Plain text: https://secwatch.observer/filing/0001193125-26-152826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.